Portage Biotech Inc.

NAS: PRTG

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 30, 2021, 4:41 p.m.

/zigman2/quotes/205701577/composite

$

14.73

Change

0.00 0.00%

Volume

Volume 217

Quotes are delayed by 20 min

/zigman2/quotes/205701577/composite

Today's close

$ 15.00

$ 14.73

Change

-0.27 -1.80%

Day low

Day high

$14.36

$15.41

Open

52 week low

52 week high

$13.00

$44.98

Open

Company Description

Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. Its portfolio includes nine subsidiary companies, whose products or technologies have established scientific rationales, including intratumorals, nano...

Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. Its portfolio includes nine subsidiary companies, whose products or technologies have established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. The firm provides funding, strategic business and clinical counsel, and shared services to treat different types of cancers. The company was founded in 1973 and is headquartered in Toronto, Canada.

Valuation

Price to Book Ratio

3.67

Enterprise Value to EBITDA

-15.86

Total Debt to Enterprise Value

0.00

Efficiency

Liquidity

Current Ratio

1.54

Quick Ratio

1.54

Cash Ratio

0.86

Profitability

Return on Assets

-9.10

Return on Equity

-15.99

Return on Total Capital

-8.38

Return on Invested Capital

-15.73

Capital Structure

Total Debt to Total Equity

0.15

Total Debt to Total Capital

0.15

Total Debt to Total Assets

0.09

Officers and Executives

Name Age Officer Since Title
Dr. Gregory H. Bailey 64 1973 Chairman
Dr. Ian B. Walters 52 2016 Chief Executive Officer & Director
Mr. Steve Innaimo - - VP-Project Management & Operations
Mr. Allan Lee Shaw 56 2020 Chief Financial Officer
Dr. Robert A. Kramer 68 - Chief Scientific Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/03/2021 James Mellon
117,193   0
03/02/2021 Ian B. Walters
117,193   0
01/13/2021 Ian B. Walters
152,000   0
12/20/2020 Gregory H. Bailey
117,193   0
12/20/2020 Ian B. Walters
117,193   0
10/14/2020 Kamlesh Shah
2,259   14,999
10/14/2020 Kamlesh Shah
2,259   14,999
10/13/2020 Steven Michael Mintz
11,295   74,998
10/13/2020 Steven Michael Mintz
5,647   37,496
06/12/2020 Steven Michael Mintz
1,486   0
06/12/2020 Steven Michael Mintz
10,000   100,000
06/12/2020 Steven Michael Mintz
5,000   50,000
06/12/2020 Gregory H. Bailey
100,000   1,000,000
06/12/2020 Kamlesh Shah
10,000   100,000
06/08/2020 Steven Michael Mintz
2,300   0
06/08/2020 Steven Michael Mintz
2,300   0
06/08/2020 Steven Michael Mintz
2,300   0
06/05/2020 Steven Michael Mintz
54,351   0
06/05/2020 Steven Michael Mintz
49,410   0
06/05/2020 Steven Michael Mintz
53,460   0
06/05/2020 Steven Michael Mintz
134,007   0
06/05/2020 Steven Michael Mintz
134,006   0
06/05/2020 Steven Michael Mintz
200   0
06/05/2020 Steven Michael Mintz
200   0
06/05/2020 Steven Michael Mintz
200   0
06/05/2020 Steven Michael Mintz
1,528,453   0
06/05/2020 Steven Michael Mintz
1,528,452   0
06/05/2020 Steven Michael Mintz
1,528,452   0
06/05/2020 Steven Michael Mintz
1,389,502   0
06/05/2020 Steven Michael Mintz
1,254,938   0
06/05/2020 Steven Michael Mintz
1,254,937   0
06/05/2020 Steven Michael Mintz
54,708   0
06/05/2020 Steven Michael Mintz
54,707   0
06/05/2020 Steven Michael Mintz
54,530   0
06/05/2020 Steven Michael Mintz
54,529   0
06/05/2020 Steven Michael Mintz
596,400   0
06/05/2020 Gregory H. Bailey
332,031,402   0
06/05/2020 James Mellon
309,687,540   0
06/05/2020 Ian B. Walters
6,234,373   0
06/05/2020 Declan Doogan
37,256,068   0
06/05/2020 Kamlesh Shah
10,183,720   0
06/05/2020 Gregory H. Bailey
3,320,314   0
06/05/2020 James Mellon
3,096,875   0
06/05/2020 Ian B. Walters
62,344   0
06/05/2020 Declan Doogan
372,561   0
06/05/2020 Kamlesh Shah
101,837   0
06/03/2020 Steven Michael Mintz
306,344   0
/news/latest/company/us/prtg

MarketWatch News on PRTG

  1. Portage Biotech started at outperform with $30 stock price target at Oppenheimer

    6:15 a.m. Sept. 21, 2021

    - Tomi Kilgore

  2. Portage Biotech started at buy with $40 stock price target at B. Riley

    6:35 a.m. Sept. 2, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/prtg

Other News on PRTG

  1. Portage Biotech joins Russell 2000 Index

    9:07 a.m. June 29, 2021

    - Seeking Alpha

  2. Wall Street Breakfast: What Moved Markets

    7:11 a.m. June 26, 2021

    - Seeking Alpha

  3. Portage Biotech shares plunge on $23M equity raise

    8:26 a.m. June 24, 2021

    - Seeking Alpha

  4. BIIB, TALO among premarket losers

    7:22 a.m. June 24, 2021

    - Seeking Alpha

  5. Portage Biotech proposes share offering

    3:19 p.m. June 23, 2021

    - Seeking Alpha

  6. Portage Biotech doses first patient in early-stage cancer study

    8:20 a.m. April 8, 2021

    - Seeking Alpha

  7. Portage to acquire SalvaRx Limited

    12:43 p.m. Aug. 14, 2018

    - Seeking Alpha

At a Glance

Portage Biotech, Inc.

Craigmuir Chambers

Road Town, TO VG1110

Phone

1 4169291806

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

03/2022

Revenue

N/A

Net Income

$-15.83M

Employees

-

/news/pressrelease/company/us/prtg

Press Releases on PRTG

  1. Portage Biotech Issues Letter to Shareholders

    7:00 a.m. Aug. 12, 2021

    - GlobeNewswire

  2. Portage Biotech Added to Russell 2000(R) Index

    8:04 a.m. June 29, 2021

    - Newsfile Corp

  3. Portage Announces Filing of Third Quarter Financial Statements

    8:02 a.m. March 2, 2021

    - Newsfile Corp

  4. Portage Commences Trading on Nasdaq

    8:01 a.m. Feb. 25, 2021

    - Newsfile Corp

  5. Loading more headlines...
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.